XML 58 R44.htm IDEA: XBRL DOCUMENT v3.25.0.1
Restructuring (Tables)
12 Months Ended
Dec. 31, 2024
Restructuring and Related Activities [Abstract]  
Schedule of Share-based Payment Arrangement, Expensed and Capitalized, Amount Total stock-based compensation expense was as follows (in thousands):
For the Years Ended December 31,
20242023
Cost of revenue
$1,907 $1,986 
Research and development
11,277 9,218 
Sales and marketing
9,505 8,801 
General and administrative
5,939 5,172 
Total stock-based compensation expense (1)
$28,628 $25,177 

(1) Stock-based compensation expense includes restructuring charges of $2.5 million and $0.1 million, incurred during the years ended December 31, 2024 and 2023. Of the $2.5 million in stock-based compensation restructuring charges incurred during the year ended December 31, 2024, $0.3 million related to cost of revenue, $0.9 million related to research and development costs, $1.2 million, related to sales and marketing costs, and $0.1 million related to general and administrative costs. Of the $0.1 million in stock-based compensation restructuring charges occurred during 2023. $0.1 million related to sales and marketing costs.
The following table presents the stock-based compensation costs as reported in the consolidated statements of operations and comprehensive loss for the years ended December 31, 2024 and December 31, 2023 (in thousands):
For the Years Ended
December 31,
Stock-based Compensation
20242023
Cost of revenue$291 $— 
Research and development885 — 
Sales and marketing1,225 80 
General and administrative123 45 
Total
$2,524 $125 
Schedule of Restructuring and Related Costs
A summary of the restructuring charges related to the 2024 Restructuring Plan and the 2023 Restructuring Plan as reported in the consolidated statements of operations and comprehensive loss for the years ended December 31, 2024 and 2023 are presented in the table below. Of the total charges incurred during the year ended December 31, 2023, $0.7 million were related to involuntary terminations. All costs during the year ended December 31, 2024 were related to involuntary terminations.

For the Years Ended
December 31,
20242023
Total Restructuring Charges
(in thousands)
Cost of revenue$460 $— 
Research and development1,278 2,311 
Sales and marketing1,867 1,025 
General and administrative (1)
1,256 280 
Total
$4,861 $3,616 
(1) General and administrative includes $0.9 million related to the impairment of the right-of-use asset related to the lease of the Company’s corporate headquarters.
Schedule of Restructuring Reserve by Type of Cost
The following table presents a summary of the liabilities related to the 2024 Restructuring Plan that are included within accrued expenses and other current liabilities on the consolidated balance sheet (in thousands):
Balance as of January 1, 2024
$— 
Charges incurred
3,928 
Noncash stock-based compensation
(2,524)
Cash payments during the period(1,049)
Balance as of December 31, 2024
$355 
(1) Charges incurred exclude right-of-use asset impairment of $0.9 million.

The following table presents a summary of the liabilities related to the 2023 Restructuring Plan that were included within accrued expenses and other current liabilities on the consolidated balance sheet, (in thousands):

Balance as of January 1, 2023$— 
Severance and other personnel costs3,616 
Cash payments during the period(3,616)
Balance as of December 31, 2023
$—